

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 7.49076634 |
| 2 | translational termination (GO:0006415) | 7.06256390 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 6.50875309 |
| 4 | DNA deamination (GO:0045006) | 6.20282884 |
| 5 | protein targeting to ER (GO:0045047) | 6.07690337 |
| 6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.04933034 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 6.02108802 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 5.98919267 |
| 9 | translational elongation (GO:0006414) | 5.94338447 |
| 10 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.76699441 |
| 11 | protein localization to endoplasmic reticulum (GO:0070972) | 5.73348820 |
| 12 | viral life cycle (GO:0019058) | 5.60805259 |
| 13 | cellular protein complex disassembly (GO:0043624) | 5.27797533 |
| 14 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.23712831 |
| 15 | translational initiation (GO:0006413) | 5.01789536 |
| 16 | maturation of SSU-rRNA (GO:0030490) | 4.78945083 |
| 17 | protein complex disassembly (GO:0043241) | 4.72492831 |
| 18 | macromolecular complex disassembly (GO:0032984) | 4.35721939 |
| 19 | mannose metabolic process (GO:0006013) | 4.12211608 |
| 20 | protein targeting to membrane (GO:0006612) | 4.02170078 |
| 21 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.83311002 |
| 22 | mRNA catabolic process (GO:0006402) | 3.63366926 |
| 23 | translation (GO:0006412) | 3.62253242 |
| 24 | pentose metabolic process (GO:0019321) | 3.58700053 |
| 25 | thymic T cell selection (GO:0045061) | 3.58382907 |
| 26 | modulation by virus of host process (GO:0019054) | 3.54362388 |
| 27 | tolerance induction (GO:0002507) | 3.53861286 |
| 28 | RNA catabolic process (GO:0006401) | 3.45047129 |
| 29 | positive thymic T cell selection (GO:0045059) | 3.44953598 |
| 30 | modulation by symbiont of host cellular process (GO:0044068) | 3.40940249 |
| 31 | ribosomal large subunit biogenesis (GO:0042273) | 3.38883963 |
| 32 | heme biosynthetic process (GO:0006783) | 3.28491906 |
| 33 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.28172925 |
| 34 | response to muramyl dipeptide (GO:0032495) | 3.24306940 |
| 35 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.09892312 |
| 36 | heme metabolic process (GO:0042168) | 3.08641435 |
| 37 | apoptotic process involved in morphogenesis (GO:0060561) | 3.08318162 |
| 38 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.07377994 |
| 39 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.05365241 |
| 40 | response to peptidoglycan (GO:0032494) | 3.03522545 |
| 41 | negative regulation of cell killing (GO:0031342) | 3.00248925 |
| 42 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.00248925 |
| 43 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.99832842 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 2.91801436 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.91801436 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.91801436 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.91801436 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 2.91801436 |
| 49 | positive regulation by symbiont of host defense response (GO:0052509) | 2.91801436 |
| 50 | T cell selection (GO:0045058) | 2.91171720 |
| 51 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.90759178 |
| 52 | granulocyte differentiation (GO:0030851) | 2.90753565 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 2.87248275 |
| 54 | regulation of histone H3-K27 methylation (GO:0061085) | 2.86340492 |
| 55 | embryonic process involved in female pregnancy (GO:0060136) | 2.85356025 |
| 56 | regulation of gamma-delta T cell activation (GO:0046643) | 2.85022788 |
| 57 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.84420135 |
| 58 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84133686 |
| 59 | leukocyte aggregation (GO:0070486) | 2.83263744 |
| 60 | platelet dense granule organization (GO:0060155) | 2.82813780 |
| 61 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.82487491 |
| 62 | megakaryocyte development (GO:0035855) | 2.79522794 |
| 63 | protein localization to endosome (GO:0036010) | 2.78908564 |
| 64 | response to laminar fluid shear stress (GO:0034616) | 2.78689942 |
| 65 | axonemal dynein complex assembly (GO:0070286) | 2.78558020 |
| 66 | axon ensheathment in central nervous system (GO:0032291) | 2.78490609 |
| 67 | central nervous system myelination (GO:0022010) | 2.78490609 |
| 68 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.77810359 |
| 69 | pseudouridine synthesis (GO:0001522) | 2.77713630 |
| 70 | establishment of protein localization to membrane (GO:0090150) | 2.76642863 |
| 71 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.76442188 |
| 72 | DNA strand elongation (GO:0022616) | 2.75942410 |
| 73 | ncRNA 3-end processing (GO:0043628) | 2.74347302 |
| 74 | activation of MAPKKK activity (GO:0000185) | 2.73963279 |
| 75 | UTP biosynthetic process (GO:0006228) | 2.73600187 |
| 76 | GTP biosynthetic process (GO:0006183) | 2.73294320 |
| 77 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.72669095 |
| 78 | histone H4 deacetylation (GO:0070933) | 2.72341356 |
| 79 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.71190003 |
| 80 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.71190003 |
| 81 | rRNA processing (GO:0006364) | 2.70328407 |
| 82 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.69546215 |
| 83 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.67180192 |
| 84 | regulation of response to osmotic stress (GO:0047484) | 2.66241501 |
| 85 | germinal center formation (GO:0002467) | 2.65994786 |
| 86 | proline metabolic process (GO:0006560) | 2.65863755 |
| 87 | proline biosynthetic process (GO:0006561) | 2.65336764 |
| 88 | negative regulation of cell size (GO:0045792) | 2.63522848 |
| 89 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.63064060 |
| 90 | formation of translation preinitiation complex (GO:0001731) | 2.62884231 |
| 91 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.62758052 |
| 92 | CTP biosynthetic process (GO:0006241) | 2.61765137 |
| 93 | CTP metabolic process (GO:0046036) | 2.61765137 |
| 94 | UTP metabolic process (GO:0046051) | 2.61449285 |
| 95 | negative thymic T cell selection (GO:0045060) | 2.61356403 |
| 96 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.60257731 |
| 97 | cellular component biogenesis (GO:0044085) | 2.58503523 |
| 98 | DNA replication initiation (GO:0006270) | 2.58287578 |
| 99 | activation of JUN kinase activity (GO:0007257) | 2.57725376 |
| 100 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.57559902 |
| 101 | protein targeting (GO:0006605) | 2.57553064 |
| 102 | rRNA metabolic process (GO:0016072) | 2.57425170 |
| 103 | detection of bacterium (GO:0016045) | 2.57152180 |
| 104 | positive T cell selection (GO:0043368) | 2.55832700 |
| 105 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.55304769 |
| 106 | histone H3 deacetylation (GO:0070932) | 2.55132622 |
| 107 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.54322509 |
| 108 | positive regulation of extracellular matrix organization (GO:1903055) | 2.53632487 |
| 109 | DNA unwinding involved in DNA replication (GO:0006268) | 2.53259940 |
| 110 | negative regulation of interleukin-2 production (GO:0032703) | 2.53257196 |
| 111 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.50967313 |
| 112 | cellular response to virus (GO:0098586) | 2.50406097 |
| 113 | endothelial cell chemotaxis (GO:0035767) | 2.50378193 |
| 114 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.50128211 |
| 115 | detection of other organism (GO:0098543) | 2.49506089 |
| 116 | nuclear envelope reassembly (GO:0031468) | 2.49438087 |
| 117 | mitotic nuclear envelope reassembly (GO:0007084) | 2.49438087 |
| 118 | establishment of protein localization to organelle (GO:0072594) | 2.48482836 |
| 119 | Golgi transport vesicle coating (GO:0048200) | 2.48009954 |
| 120 | COPI coating of Golgi vesicle (GO:0048205) | 2.48009954 |
| 121 | definitive hemopoiesis (GO:0060216) | 2.46350766 |
| 122 | regulation of extracellular matrix disassembly (GO:0010715) | 2.45977610 |
| 123 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.45091744 |
| 124 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.44809572 |
| 125 | negative regulation of RNA splicing (GO:0033119) | 2.44511606 |
| 126 | regulation of monocyte differentiation (GO:0045655) | 2.43617737 |
| 127 | pentose-phosphate shunt (GO:0006098) | 2.43166556 |
| 128 | L-serine metabolic process (GO:0006563) | 2.42435936 |
| 129 | regulation of ARF protein signal transduction (GO:0032012) | 2.41101293 |
| 130 | macrophage activation involved in immune response (GO:0002281) | 2.41010705 |
| 131 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.40634852 |
| 132 | regulation of ARF GTPase activity (GO:0032312) | 2.39926073 |
| 133 | neutrophil activation involved in immune response (GO:0002283) | 2.39257512 |
| 134 | negative regulation of myotube differentiation (GO:0010832) | 2.38977974 |
| 135 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.38817374 |
| 136 | negative regulation of phagocytosis (GO:0050765) | 2.38754976 |
| 137 | proteasome assembly (GO:0043248) | 2.38353000 |
| 138 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.38071840 |
| 139 | signal complex assembly (GO:0007172) | 2.38003330 |
| 140 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.36632475 |
| 141 | axoneme assembly (GO:0035082) | 2.36606291 |
| 142 | cilium movement (GO:0003341) | 2.36282608 |
| 143 | hypotonic response (GO:0006971) | 2.36233131 |
| 144 | negative T cell selection (GO:0043383) | 2.36055624 |
| 145 | regulation of chromatin binding (GO:0035561) | 2.35916121 |
| 146 | positive regulation of histone deacetylation (GO:0031065) | 2.35575104 |
| 147 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.34621366 |
| 148 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.34067595 |
| 149 | response to interferon-beta (GO:0035456) | 2.33894895 |
| 150 | porphyrin-containing compound metabolic process (GO:0006778) | 2.32833529 |
| 151 | heme transport (GO:0015886) | 2.32803498 |
| 152 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.32625810 |
| 153 | telomere maintenance via recombination (GO:0000722) | 2.32285636 |
| 154 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.32257372 |
| 155 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.31707169 |
| 156 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.31115048 |
| 157 | viral mRNA export from host cell nucleus (GO:0046784) | 2.30388434 |
| 158 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.30361470 |
| 159 | positive regulation by host of viral transcription (GO:0043923) | 2.29352459 |
| 160 | retinoic acid receptor signaling pathway (GO:0048384) | 2.28534149 |
| 161 | amyloid precursor protein catabolic process (GO:0042987) | 2.28267616 |
| 162 | negative regulation of granulocyte differentiation (GO:0030853) | 2.27169905 |
| 163 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.25461359 |
| 164 | maternal placenta development (GO:0001893) | 2.25252429 |
| 165 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.24959471 |
| 166 | ATP synthesis coupled proton transport (GO:0015986) | 2.24831969 |
| 167 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.24831969 |
| 168 | myeloid dendritic cell differentiation (GO:0043011) | 2.24584627 |
| 169 | regulation of superoxide anion generation (GO:0032928) | 2.23548471 |
| 170 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.23502801 |
| 171 | motile cilium assembly (GO:0044458) | 2.23501741 |
| 172 | viral protein processing (GO:0019082) | 2.23251226 |
| 173 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.23224105 |
| 174 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.23046360 |
| 175 | B cell receptor signaling pathway (GO:0050853) | 2.22872993 |
| 176 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.22780904 |
| 177 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.22656382 |
| 178 | activation of Rac GTPase activity (GO:0032863) | 2.22124713 |
| 179 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.22093951 |
| 180 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.22087308 |
| 181 | retrograde transport, endosome to Golgi (GO:0042147) | 2.21157471 |
| 182 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.20007260 |
| 183 | metallo-sulfur cluster assembly (GO:0031163) | 2.19607011 |
| 184 | iron-sulfur cluster assembly (GO:0016226) | 2.19607011 |
| 185 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.19343429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.37839096 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.58330528 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.17578836 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.98977914 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.93672028 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.77263706 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.60074285 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.52854779 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.48068196 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.28065374 |
| 11 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26561722 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.22762231 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21408298 |
| 14 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.21399624 |
| 15 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.17125314 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.16268322 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14938065 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.11029550 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07926758 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.06444368 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.05980399 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.05090788 |
| 23 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.02126546 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.00715453 |
| 25 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.98482662 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94850055 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94258141 |
| 28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.90275736 |
| 29 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.81989717 |
| 30 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.80898932 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.79464108 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78741406 |
| 33 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.77894803 |
| 34 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.76735423 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75819196 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.75306358 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.73703380 |
| 38 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.71690410 |
| 39 | P68_20966046_ChIP-Seq_HELA_Human | 1.70965170 |
| 40 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.67251622 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.66582968 |
| 42 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.65380817 |
| 43 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65164585 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.64303384 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.63051389 |
| 46 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.61980304 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61241664 |
| 48 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.59447109 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.59327018 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56396328 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.52010427 |
| 52 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.51297681 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49539619 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.49249980 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48650395 |
| 56 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.46967785 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45375238 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.44685090 |
| 59 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.44596802 |
| 60 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.43331190 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.40685692 |
| 62 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.38023134 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37992014 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37588394 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.36719076 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35870368 |
| 67 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.34707872 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.34517120 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34464276 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.34453596 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34353520 |
| 72 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.33918972 |
| 73 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.32948910 |
| 74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32870375 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30713005 |
| 76 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.30564525 |
| 77 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.30365258 |
| 78 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.28727801 |
| 79 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.28554197 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27254134 |
| 81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27224956 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26987596 |
| 83 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.26485029 |
| 84 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.25930318 |
| 85 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25774007 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25668880 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25489622 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25245805 |
| 89 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24744832 |
| 90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24728047 |
| 91 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.24047787 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23957371 |
| 93 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.23808895 |
| 94 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.23737410 |
| 95 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.23235823 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22868016 |
| 97 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.22301255 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21932583 |
| 99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20917310 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20264317 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20181175 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20142751 |
| 103 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.19771589 |
| 104 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.18303539 |
| 105 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17930022 |
| 106 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.17789725 |
| 107 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17200843 |
| 108 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16827893 |
| 109 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16670104 |
| 110 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16440398 |
| 111 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.16307273 |
| 112 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15557555 |
| 113 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.15541703 |
| 114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15487284 |
| 115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15367449 |
| 116 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15049840 |
| 117 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14830876 |
| 118 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.14587835 |
| 119 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.14487406 |
| 120 | MYB_26560356_Chip-Seq_TH1_Human | 1.13809910 |
| 121 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13324575 |
| 122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13084035 |
| 123 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12618150 |
| 124 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12503926 |
| 125 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.12338791 |
| 126 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11943181 |
| 127 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11819435 |
| 128 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11500120 |
| 129 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11412651 |
| 130 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11330766 |
| 131 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.10937464 |
| 132 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10543754 |
| 133 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.10284901 |
| 134 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.10125676 |
| 135 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09630144 |
| 136 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08680095 |
| 137 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07433311 |
| 138 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.07428802 |
| 139 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07249981 |
| 140 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06726818 |
| 141 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06454893 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05932624 |
| 143 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05550409 |
| 144 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05033389 |
| 145 | MYB_26560356_Chip-Seq_TH2_Human | 1.05007172 |
| 146 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04785758 |
| 147 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04603349 |
| 148 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04421046 |
| 149 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03648333 |
| 150 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03402637 |
| 151 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03288497 |
| 152 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02637490 |
| 153 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01717789 |
| 154 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01310844 |
| 155 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01003214 |
| 156 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.00857366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008260_abnormal_autophagy | 3.30608938 |
| 2 | MP0000685_abnormal_immune_system | 2.82782494 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 2.71767097 |
| 4 | MP0003172_abnormal_lysosome_physiology | 2.68324588 |
| 5 | MP0002132_abnormal_respiratory_system | 2.54137304 |
| 6 | MP0004381_abnormal_hair_follicle | 2.43741863 |
| 7 | MP0003656_abnormal_erythrocyte_physiolo | 2.38509572 |
| 8 | MP0005076_abnormal_cell_differentiation | 2.35524190 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 2.31858226 |
| 10 | MP0001545_abnormal_hematopoietic_system | 2.31858226 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.23971477 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.23571164 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.14338386 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 2.06202444 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.03237162 |
| 16 | MP0009278_abnormal_bone_marrow | 1.95958680 |
| 17 | MP0002398_abnormal_bone_marrow | 1.95924091 |
| 18 | MP0001800_abnormal_humoral_immune | 1.92868543 |
| 19 | MP0003136_yellow_coat_color | 1.89128531 |
| 20 | MP0005671_abnormal_response_to | 1.89039536 |
| 21 | MP0005451_abnormal_body_composition | 1.88877384 |
| 22 | MP0005025_abnormal_response_to | 1.88069134 |
| 23 | MP0003436_decreased_susceptibility_to | 1.87362273 |
| 24 | MP0000689_abnormal_spleen_morphology | 1.80712134 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 1.80090884 |
| 26 | MP0009785_altered_susceptibility_to | 1.79648233 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.79256081 |
| 28 | MP0002405_respiratory_system_inflammati | 1.78160492 |
| 29 | MP0000678_abnormal_parathyroid_gland | 1.77341991 |
| 30 | MP0002723_abnormal_immune_serum | 1.77049216 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.75593755 |
| 32 | MP0000490_abnormal_crypts_of | 1.73175392 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.71706392 |
| 34 | MP0001873_stomach_inflammation | 1.71430738 |
| 35 | MP0009840_abnormal_foam_cell | 1.71239366 |
| 36 | MP0005083_abnormal_biliary_tract | 1.70908116 |
| 37 | MP0002722_abnormal_immune_system | 1.70408621 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.67674286 |
| 39 | MP0001849_ear_inflammation | 1.67413137 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.66903704 |
| 41 | MP0001819_abnormal_immune_cell | 1.66206079 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.65689704 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.65327706 |
| 44 | MP0000858_altered_metastatic_potential | 1.64833465 |
| 45 | MP0000716_abnormal_immune_system | 1.64724202 |
| 46 | MP0001790_abnormal_immune_system | 1.63557018 |
| 47 | MP0005387_immune_system_phenotype | 1.63557018 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.62335665 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.59885557 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.57628025 |
| 51 | MP0006082_CNS_inflammation | 1.55792995 |
| 52 | MP0002429_abnormal_blood_cell | 1.55305383 |
| 53 | MP0002796_impaired_skin_barrier | 1.50412935 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.48781733 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.45368424 |
| 56 | MP0003724_increased_susceptibility_to | 1.41328832 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.41153231 |
| 58 | MP0003693_abnormal_embryo_hatching | 1.38679133 |
| 59 | MP0003866_abnormal_defecation | 1.38388561 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.37134164 |
| 61 | MP0005085_abnormal_gallbladder_physiolo | 1.34244626 |
| 62 | MP0008057_abnormal_DNA_replication | 1.33624574 |
| 63 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32666333 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.32469645 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.31256238 |
| 66 | MP0003091_abnormal_cell_migration | 1.30798593 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.30491120 |
| 68 | MP0001348_abnormal_lacrimal_gland | 1.29521942 |
| 69 | MP0002653_abnormal_ependyma_morphology | 1.28288503 |
| 70 | MP0005409_darkened_coat_color | 1.27235231 |
| 71 | MP0005666_abnormal_adipose_tissue | 1.27057041 |
| 72 | MP0002419_abnormal_innate_immunity | 1.25206355 |
| 73 | MP0003186_abnormal_redox_activity | 1.24879328 |
| 74 | MP0005310_abnormal_salivary_gland | 1.24499941 |
| 75 | MP0000733_abnormal_muscle_development | 1.22748545 |
| 76 | MP0003566_abnormal_cell_adhesion | 1.21530405 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 1.19015807 |
| 78 | MP0005365_abnormal_bile_salt | 1.18843221 |
| 79 | MP0001853_heart_inflammation | 1.18747694 |
| 80 | MP0004510_myositis | 1.17343193 |
| 81 | MP0005360_urolithiasis | 1.15919394 |
| 82 | MP0005410_abnormal_fertilization | 1.14949934 |
| 83 | MP0002019_abnormal_tumor_incidence | 1.14219817 |
| 84 | MP0008469_abnormal_protein_level | 1.14169040 |
| 85 | MP0004957_abnormal_blastocyst_morpholog | 1.14093807 |
| 86 | MP0004858_abnormal_nervous_system | 1.13980945 |
| 87 | MP0003329_amyloid_beta_deposits | 1.13624389 |
| 88 | MP0005375_adipose_tissue_phenotype | 1.13108679 |
| 89 | MP0002998_abnormal_bone_remodeling | 1.11869051 |
| 90 | MP0003303_peritoneal_inflammation | 1.08504905 |
| 91 | MP0001845_abnormal_inflammatory_respons | 1.07715846 |
| 92 | MP0003075_altered_response_to | 1.06895093 |
| 93 | MP0003878_abnormal_ear_physiology | 1.06653814 |
| 94 | MP0005377_hearing/vestibular/ear_phenot | 1.06653814 |
| 95 | MP0003111_abnormal_nucleus_morphology | 1.06567047 |
| 96 | MP0004947_skin_inflammation | 1.04308724 |
| 97 | MP0000920_abnormal_myelination | 1.02946201 |
| 98 | MP0008995_early_reproductive_senescence | 1.02916046 |
| 99 | MP0003279_aneurysm | 1.02609038 |
| 100 | MP0001851_eye_inflammation | 1.02126139 |
| 101 | MP0002060_abnormal_skin_morphology | 1.00898427 |
| 102 | MP0000003_abnormal_adipose_tissue | 0.99709739 |
| 103 | MP0009931_abnormal_skin_appearance | 0.99388852 |
| 104 | MP0003077_abnormal_cell_cycle | 0.98572773 |
| 105 | MP0003828_pulmonary_edema | 0.98016836 |
| 106 | MP0001216_abnormal_epidermal_layer | 0.96364612 |
| 107 | MP0008961_abnormal_basal_metabolism | 0.94270028 |
| 108 | MP0001958_emphysema | 0.94050827 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.93678003 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 0.91803585 |
| 111 | MP0005058_abnormal_lysosome_morphology | 0.91445823 |
| 112 | MP0000313_abnormal_cell_death | 0.90122059 |
| 113 | MP0001727_abnormal_embryo_implantation | 0.89614018 |
| 114 | MP0004147_increased_porphyrin_level | 0.86399089 |
| 115 | MP0003283_abnormal_digestive_organ | 0.85288274 |
| 116 | MP0005621_abnormal_cell_physiology | 0.84941556 |
| 117 | MP0002249_abnormal_larynx_morphology | 0.84739605 |
| 118 | MP0005390_skeleton_phenotype | 0.83787615 |
| 119 | MP0005023_abnormal_wound_healing | 0.83208463 |
| 120 | MP0010094_abnormal_chromosome_stability | 0.83066965 |
| 121 | MP0010352_gastrointestinal_tract_polyps | 0.82881113 |
| 122 | MP0008932_abnormal_embryonic_tissue | 0.81342595 |
| 123 | MP0001663_abnormal_digestive_system | 0.81120748 |
| 124 | MP0003786_premature_aging | 0.79741474 |
| 125 | MP0000477_abnormal_intestine_morphology | 0.79416719 |
| 126 | MP0000604_amyloidosis | 0.78849604 |
| 127 | MP0003011_delayed_dark_adaptation | 0.77469357 |
| 128 | MP0005636_abnormal_mineral_homeostasis | 0.77443331 |
| 129 | MP0000609_abnormal_liver_physiology | 0.76463589 |
| 130 | MP0000681_abnormal_thyroid_gland | 0.76456026 |
| 131 | MP0005501_abnormal_skin_physiology | 0.75517118 |
| 132 | MP0005319_abnormal_enzyme/_coenzyme | 0.73108103 |
| 133 | MP0002933_joint_inflammation | 0.72657573 |
| 134 | MP0001666_abnormal_nutrient_absorption | 0.72257212 |
| 135 | MP0005381_digestive/alimentary_phenotyp | 0.70767698 |
| 136 | MP0000598_abnormal_liver_morphology | 0.70587285 |
| 137 | MP0000613_abnormal_salivary_gland | 0.70435784 |
| 138 | MP0000750_abnormal_muscle_regeneration | 0.69565795 |
| 139 | MP0002089_abnormal_postnatal_growth/wei | 0.68694406 |
| 140 | MP0002098_abnormal_vibrissa_morphology | 0.67845619 |
| 141 | MP0002006_tumorigenesis | 0.67794197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.32411117 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 6.12439345 |
| 3 | Reticulocytopenia (HP:0001896) | 4.40725548 |
| 4 | Nasal polyposis (HP:0100582) | 4.14032127 |
| 5 | Abnormality of the nasal mucosa (HP:0000433) | 3.77464476 |
| 6 | Abnormal ciliary motility (HP:0012262) | 3.67261371 |
| 7 | Obstructive sleep apnea (HP:0002870) | 3.66382642 |
| 8 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.65704160 |
| 9 | Macrocytic anemia (HP:0001972) | 3.62471717 |
| 10 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.61705805 |
| 11 | Petechiae (HP:0000967) | 3.57931443 |
| 12 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.54776454 |
| 13 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.54776454 |
| 14 | Pallor (HP:0000980) | 3.54258390 |
| 15 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.42371108 |
| 16 | Exertional dyspnea (HP:0002875) | 3.40918277 |
| 17 | Increased intramyocellular lipid droplets (HP:0012240) | 3.25314799 |
| 18 | Increased hepatocellular lipid droplets (HP:0006565) | 3.21159899 |
| 19 | Pustule (HP:0200039) | 3.15910229 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.14747684 |
| 21 | Broad face (HP:0000283) | 3.03180049 |
| 22 | Lipid accumulation in hepatocytes (HP:0006561) | 3.02489903 |
| 23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.01164119 |
| 24 | Hyperacusis (HP:0010780) | 2.99067295 |
| 25 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.98811410 |
| 26 | Thrombocytosis (HP:0001894) | 2.96611020 |
| 27 | Increased muscle lipid content (HP:0009058) | 2.95929501 |
| 28 | Renal Fanconi syndrome (HP:0001994) | 2.93331088 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 2.92355807 |
| 30 | Colitis (HP:0002583) | 2.87801360 |
| 31 | Prolonged bleeding time (HP:0003010) | 2.83727447 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.81932503 |
| 33 | IgM deficiency (HP:0002850) | 2.80751989 |
| 34 | Recurrent sinusitis (HP:0011108) | 2.80724741 |
| 35 | Rhinitis (HP:0012384) | 2.79912917 |
| 36 | Recurrent bronchitis (HP:0002837) | 2.74980479 |
| 37 | Chronic otitis media (HP:0000389) | 2.70398922 |
| 38 | Increased serum ferritin (HP:0003281) | 2.69323426 |
| 39 | Abnormality of reticulocytes (HP:0004312) | 2.63132826 |
| 40 | Asplenia (HP:0001746) | 2.61362713 |
| 41 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.59965087 |
| 42 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.59965087 |
| 43 | Chronic sinusitis (HP:0011109) | 2.59111744 |
| 44 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57789849 |
| 45 | Bronchiectasis (HP:0002110) | 2.56462332 |
| 46 | Distal lower limb muscle weakness (HP:0009053) | 2.55992301 |
| 47 | Hypochromic anemia (HP:0001931) | 2.55771264 |
| 48 | Achilles tendon contracture (HP:0001771) | 2.55725262 |
| 49 | Vertebral compression fractures (HP:0002953) | 2.54376495 |
| 50 | Mitochondrial inheritance (HP:0001427) | 2.51875072 |
| 51 | Increased IgE level (HP:0003212) | 2.50593708 |
| 52 | Microcytic anemia (HP:0001935) | 2.49913997 |
| 53 | Abnormality of the fingertips (HP:0001211) | 2.49112869 |
| 54 | Epistaxis (HP:0000421) | 2.48382966 |
| 55 | Stridor (HP:0010307) | 2.43893476 |
| 56 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.43076566 |
| 57 | Hepatocellular necrosis (HP:0001404) | 2.40745240 |
| 58 | Distal lower limb amyotrophy (HP:0008944) | 2.40486903 |
| 59 | Atelectasis (HP:0100750) | 2.39448456 |
| 60 | Distal upper limb amyotrophy (HP:0007149) | 2.39416490 |
| 61 | Upper limb amyotrophy (HP:0009129) | 2.39416490 |
| 62 | Thin bony cortex (HP:0002753) | 2.39305875 |
| 63 | Poikiloderma (HP:0001029) | 2.38197178 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.34237496 |
| 65 | Abnormality of iron homeostasis (HP:0011031) | 2.34098899 |
| 66 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.32348751 |
| 67 | Abnormality of T cell physiology (HP:0011840) | 2.31658631 |
| 68 | Abnormality of the Achilles tendon (HP:0005109) | 2.30375892 |
| 69 | Bronchitis (HP:0012387) | 2.30076518 |
| 70 | Concave nail (HP:0001598) | 2.28144095 |
| 71 | Increased connective tissue (HP:0009025) | 2.26708295 |
| 72 | Acanthocytosis (HP:0001927) | 2.23929360 |
| 73 | Purpura (HP:0000979) | 2.22960381 |
| 74 | Polygenic inheritance (HP:0010982) | 2.17310989 |
| 75 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.15816824 |
| 76 | Absent/shortened dynein arms (HP:0200106) | 2.15816824 |
| 77 | 3-Methylglutaconic aciduria (HP:0003535) | 2.14682036 |
| 78 | Short nail (HP:0001799) | 2.12460044 |
| 79 | Gastrointestinal inflammation (HP:0004386) | 2.11980789 |
| 80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.10792951 |
| 81 | Abnormality of the thoracic spine (HP:0100711) | 2.10713683 |
| 82 | Hepatic necrosis (HP:0002605) | 2.09884558 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 2.09870653 |
| 84 | Cervical subluxation (HP:0003308) | 2.09396094 |
| 85 | Nuclear cataract (HP:0100018) | 2.09089327 |
| 86 | Cellulitis (HP:0100658) | 2.08648124 |
| 87 | Dysostosis multiplex (HP:0000943) | 2.07788435 |
| 88 | Obstructive lung disease (HP:0006536) | 2.07076896 |
| 89 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07076896 |
| 90 | Abnormality of T cells (HP:0002843) | 2.06010721 |
| 91 | Impaired platelet aggregation (HP:0003540) | 2.05726126 |
| 92 | Abnormal platelet function (HP:0011869) | 2.05726126 |
| 93 | Gingivitis (HP:0000230) | 2.05428271 |
| 94 | Ragged-red muscle fibers (HP:0003200) | 2.05175978 |
| 95 | Myositis (HP:0100614) | 2.04911539 |
| 96 | Inflammation of the large intestine (HP:0002037) | 2.04885581 |
| 97 | Flat acetabular roof (HP:0003180) | 2.03192093 |
| 98 | Acute necrotizing encephalopathy (HP:0006965) | 2.03041601 |
| 99 | J-shaped sella turcica (HP:0002680) | 2.02391359 |
| 100 | Aplastic anemia (HP:0001915) | 2.00997349 |
| 101 | Cerebral aneurysm (HP:0004944) | 2.00468605 |
| 102 | Reticulocytosis (HP:0001923) | 2.00463411 |
| 103 | Recurrent skin infections (HP:0001581) | 2.00214159 |
| 104 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.99098338 |
| 105 | Meningitis (HP:0001287) | 1.98270185 |
| 106 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.97035267 |
| 107 | Panhypogammaglobulinemia (HP:0003139) | 1.96857825 |
| 108 | Acute encephalopathy (HP:0006846) | 1.96679947 |
| 109 | Loss of speech (HP:0002371) | 1.96294814 |
| 110 | Abnormality of macrophages (HP:0004311) | 1.95565840 |
| 111 | Thoracic kyphosis (HP:0002942) | 1.95349675 |
| 112 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93566635 |
| 113 | Hypertensive crisis (HP:0100735) | 1.93564628 |
| 114 | Axonal loss (HP:0003447) | 1.91636728 |
| 115 | Emphysema (HP:0002097) | 1.90363063 |
| 116 | Protrusio acetabuli (HP:0003179) | 1.89591345 |
| 117 | Difficulty climbing stairs (HP:0003551) | 1.89573118 |
| 118 | Parakeratosis (HP:0001036) | 1.89213203 |
| 119 | Increased cerebral lipofuscin (HP:0011813) | 1.89089507 |
| 120 | Intrahepatic cholestasis (HP:0001406) | 1.87961649 |
| 121 | Abnormality of the aortic arch (HP:0012303) | 1.87783393 |
| 122 | Abnormal platelet volume (HP:0011876) | 1.86968779 |
| 123 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.86858775 |
| 124 | Mitral regurgitation (HP:0001653) | 1.86748066 |
| 125 | IgG deficiency (HP:0004315) | 1.86462280 |
| 126 | Hand muscle atrophy (HP:0009130) | 1.86350197 |
| 127 | Poikilocytosis (HP:0004447) | 1.85848476 |
| 128 | Respiratory difficulties (HP:0002880) | 1.85641302 |
| 129 | Recurrent otitis media (HP:0000403) | 1.85241519 |
| 130 | Abnormal hemoglobin (HP:0011902) | 1.85047250 |
| 131 | Increased variability in muscle fiber diameter (HP:0003557) | 1.84993847 |
| 132 | Diaphragmatic weakness (HP:0009113) | 1.84809438 |
| 133 | Broad distal phalanx of finger (HP:0009836) | 1.84284311 |
| 134 | Gastrointestinal stroma tumor (HP:0100723) | 1.83126481 |
| 135 | Muscle fiber atrophy (HP:0100295) | 1.83036628 |
| 136 | Long palpebral fissure (HP:0000637) | 1.82029520 |
| 137 | Neuronal loss in central nervous system (HP:0002529) | 1.81907558 |
| 138 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81873070 |
| 139 | Basal cell carcinoma (HP:0002671) | 1.81238799 |
| 140 | Ulnar bowing (HP:0003031) | 1.81078585 |
| 141 | Seborrheic dermatitis (HP:0001051) | 1.80963356 |
| 142 | Prolonged partial thromboplastin time (HP:0003645) | 1.80723221 |
| 143 | Hyperbilirubinemia (HP:0002904) | 1.79788951 |
| 144 | Spontaneous hematomas (HP:0007420) | 1.78186906 |
| 145 | Recurrent abscess formation (HP:0002722) | 1.77385112 |
| 146 | Exercise intolerance (HP:0003546) | 1.77211025 |
| 147 | Biconcave vertebral bodies (HP:0004586) | 1.75846008 |
| 148 | Supranuclear gaze palsy (HP:0000605) | 1.75608427 |
| 149 | Myopathic facies (HP:0002058) | 1.74762050 |
| 150 | Recurrent fungal infections (HP:0002841) | 1.74448333 |
| 151 | Increased CSF lactate (HP:0002490) | 1.74312164 |
| 152 | Agammaglobulinemia (HP:0004432) | 1.73871289 |
| 153 | Insomnia (HP:0100785) | 1.72971644 |
| 154 | Syringomyelia (HP:0003396) | 1.72446397 |
| 155 | Spinal cord lesions (HP:0100561) | 1.72446397 |
| 156 | Mediastinal lymphadenopathy (HP:0100721) | 1.71524643 |
| 157 | Vacuolated lymphocytes (HP:0001922) | 1.71345853 |
| 158 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.71180936 |
| 159 | Easy fatigability (HP:0003388) | 1.71130479 |
| 160 | Dislocated radial head (HP:0003083) | 1.70478979 |
| 161 | Spastic paraparesis (HP:0002313) | 1.70417668 |
| 162 | Increased serum lactate (HP:0002151) | 1.70328723 |
| 163 | Severe combined immunodeficiency (HP:0004430) | 1.70302856 |
| 164 | Recurrent viral infections (HP:0004429) | 1.70146574 |
| 165 | Esophageal neoplasm (HP:0100751) | 1.69663915 |
| 166 | Neoplasm of head and neck (HP:0012288) | 1.69663915 |
| 167 | Growth hormone excess (HP:0000845) | 1.69036160 |
| 168 | Microvesicular hepatic steatosis (HP:0001414) | 1.67485976 |
| 169 | Sparse lateral eyebrow (HP:0005338) | 1.65999250 |
| 170 | Hemorrhage of the eye (HP:0011885) | 1.64692483 |
| 171 | Foot dorsiflexor weakness (HP:0009027) | 1.64418096 |
| 172 | Cholecystitis (HP:0001082) | 1.64039905 |
| 173 | Abnormal gallbladder physiology (HP:0012438) | 1.64039905 |
| 174 | Hypercortisolism (HP:0001578) | 1.63760025 |
| 175 | Spinal cord compression (HP:0002176) | 1.63735106 |
| 176 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.63602842 |
| 177 | Recurrent cutaneous fungal infections (HP:0011370) | 1.63602842 |
| 178 | Deep palmar crease (HP:0006191) | 1.63181346 |
| 179 | Premature skin wrinkling (HP:0100678) | 1.62726459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.45345154 |
| 2 | MAP4K1 | 3.36849981 |
| 3 | PRPF4B | 3.30354635 |
| 4 | PIM2 | 3.29964151 |
| 5 | MAP3K10 | 2.84908100 |
| 6 | BLK | 2.83582597 |
| 7 | SMG1 | 2.76177800 |
| 8 | MAPK15 | 2.69076960 |
| 9 | ICK | 2.58171030 |
| 10 | TLK1 | 2.43582339 |
| 11 | MAP3K11 | 2.30107358 |
| 12 | MAP2K3 | 2.29148421 |
| 13 | NME2 | 2.23532467 |
| 14 | EEF2K | 2.07947583 |
| 15 | TESK2 | 2.07854593 |
| 16 | LRRK2 | 1.95346120 |
| 17 | KDR | 1.95039909 |
| 18 | CDK12 | 1.93537190 |
| 19 | MAP2K2 | 1.90903307 |
| 20 | RIPK4 | 1.82775459 |
| 21 | GRK6 | 1.80957858 |
| 22 | DYRK3 | 1.68932056 |
| 23 | CDK19 | 1.64680913 |
| 24 | BTK | 1.60733027 |
| 25 | RIPK1 | 1.50174530 |
| 26 | ERN1 | 1.48539661 |
| 27 | TAOK2 | 1.48025785 |
| 28 | STK10 | 1.47227652 |
| 29 | STK16 | 1.45346306 |
| 30 | TAOK1 | 1.44660719 |
| 31 | RPS6KB2 | 1.43961185 |
| 32 | MUSK | 1.41828269 |
| 33 | BUB1 | 1.40262900 |
| 34 | MAP3K3 | 1.39629529 |
| 35 | MARK2 | 1.38756404 |
| 36 | SIK2 | 1.38070114 |
| 37 | KIT | 1.33617582 |
| 38 | EPHA2 | 1.27644986 |
| 39 | SIK3 | 1.26353102 |
| 40 | FGFR4 | 1.23699872 |
| 41 | CSK | 1.19460239 |
| 42 | TBK1 | 1.19366516 |
| 43 | EPHB1 | 1.18874389 |
| 44 | DYRK1B | 1.16791253 |
| 45 | PIM1 | 1.14829087 |
| 46 | MATK | 1.14379097 |
| 47 | WEE1 | 1.12112205 |
| 48 | MAP3K14 | 1.10386832 |
| 49 | TNK2 | 1.09794415 |
| 50 | MAP3K1 | 1.09028108 |
| 51 | BCKDK | 1.08344103 |
| 52 | ILK | 1.07694315 |
| 53 | JAK3 | 1.07149208 |
| 54 | MAPK11 | 1.07147579 |
| 55 | IKBKE | 1.07031228 |
| 56 | MAP3K13 | 1.06309213 |
| 57 | PTK6 | 1.03113228 |
| 58 | CSF1R | 1.02483455 |
| 59 | MAP3K6 | 1.01703440 |
| 60 | IRAK4 | 1.01175261 |
| 61 | IKBKB | 1.00931343 |
| 62 | CDC42BPA | 0.99094631 |
| 63 | CDK7 | 0.98565575 |
| 64 | RPS6KA2 | 0.97358736 |
| 65 | RPS6KA6 | 0.96696874 |
| 66 | ZAP70 | 0.95404696 |
| 67 | RPS6KC1 | 0.93551302 |
| 68 | RPS6KL1 | 0.93551302 |
| 69 | LYN | 0.93058716 |
| 70 | DAPK3 | 0.91672886 |
| 71 | PRKD2 | 0.91387032 |
| 72 | UHMK1 | 0.90680048 |
| 73 | VRK1 | 0.89902006 |
| 74 | LCK | 0.89321028 |
| 75 | FLT3 | 0.88641026 |
| 76 | SYK | 0.88145979 |
| 77 | FGR | 0.87126066 |
| 78 | PDPK1 | 0.86745463 |
| 79 | CAMKK1 | 0.82957508 |
| 80 | MAPK4 | 0.82268980 |
| 81 | CLK1 | 0.81839928 |
| 82 | MTOR | 0.81090385 |
| 83 | MST4 | 0.79085631 |
| 84 | TYK2 | 0.76549377 |
| 85 | TTN | 0.76238572 |
| 86 | BMX | 0.74924951 |
| 87 | PRKD3 | 0.73520648 |
| 88 | TRIB3 | 0.73508719 |
| 89 | NEK2 | 0.73406332 |
| 90 | MAPKAPK5 | 0.72975303 |
| 91 | MAPK12 | 0.72668029 |
| 92 | ARAF | 0.72137304 |
| 93 | MAPKAPK3 | 0.71832395 |
| 94 | PDGFRA | 0.71755612 |
| 95 | RPS6KA5 | 0.68807023 |
| 96 | HIPK2 | 0.64716664 |
| 97 | MAP3K8 | 0.64450890 |
| 98 | SIK1 | 0.64363274 |
| 99 | PKN2 | 0.61560258 |
| 100 | MST1R | 0.61253658 |
| 101 | CHUK | 0.60888998 |
| 102 | ITK | 0.60221411 |
| 103 | MAP2K6 | 0.60019751 |
| 104 | TEC | 0.58624901 |
| 105 | STK4 | 0.57646398 |
| 106 | FES | 0.56938515 |
| 107 | KSR2 | 0.55682455 |
| 108 | PDK1 | 0.54708261 |
| 109 | RPS6KA1 | 0.52713036 |
| 110 | MKNK2 | 0.52158446 |
| 111 | TRPM7 | 0.52157787 |
| 112 | CDK4 | 0.51894373 |
| 113 | JAK1 | 0.50448471 |
| 114 | RAF1 | 0.49555847 |
| 115 | TGFBR2 | 0.48639006 |
| 116 | PAK1 | 0.48438138 |
| 117 | LMTK2 | 0.47602522 |
| 118 | RET | 0.46942118 |
| 119 | DDR2 | 0.46899535 |
| 120 | PAK2 | 0.46324252 |
| 121 | STK39 | 0.45754260 |
| 122 | MAPKAPK2 | 0.45694553 |
| 123 | AURKA | 0.45667472 |
| 124 | STK38 | 0.45314745 |
| 125 | CSNK2A2 | 0.44733983 |
| 126 | IRAK1 | 0.44693734 |
| 127 | SRPK1 | 0.43778569 |
| 128 | IRAK3 | 0.42842814 |
| 129 | EPHA3 | 0.41237829 |
| 130 | HCK | 0.41040669 |
| 131 | MAP3K7 | 0.41033040 |
| 132 | TNIK | 0.40711640 |
| 133 | PAK4 | 0.40074202 |
| 134 | TESK1 | 0.39492202 |
| 135 | MAPK7 | 0.39113428 |
| 136 | CSNK2A1 | 0.38279322 |
| 137 | BRAF | 0.37702619 |
| 138 | IRAK2 | 0.37224285 |
| 139 | TYRO3 | 0.37080057 |
| 140 | TXK | 0.36993365 |
| 141 | GSK3A | 0.36538953 |
| 142 | PRKCQ | 0.35775568 |
| 143 | AURKB | 0.35624633 |
| 144 | MAP3K2 | 0.33221467 |
| 145 | NME1 | 0.32833287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.75039318 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.90480084 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.39760624 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.44688114 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.19141407 |
| 6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.18716719 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.13850985 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.05624135 |
| 9 | VEGF signaling pathway_Homo sapiens_hsa04370 | 2.05484614 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.01726509 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.96833824 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 1.95786462 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93861326 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.92370379 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.89547434 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.87259515 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.80069661 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 1.75756711 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.72932483 |
| 20 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.68222039 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.66935530 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.66016367 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.62660154 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.61783799 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59853607 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.58636910 |
| 27 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.49902111 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.49761226 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.41261179 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.40971418 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38469283 |
| 32 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.38153900 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.36423391 |
| 34 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.34331485 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32983512 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.32305390 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32296616 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.31405891 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.31387997 |
| 40 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.30817748 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.29450905 |
| 42 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.29043350 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.28830099 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.27645573 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.27377815 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 1.26982227 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26016149 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 1.24480605 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21259691 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20855049 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 1.20095415 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.20089732 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.19319162 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.18089135 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.14759635 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12794237 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.11691135 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08560810 |
| 59 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.07287829 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06525633 |
| 61 | Glioma_Homo sapiens_hsa05214 | 1.06525251 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06017655 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 1.04336687 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.02845270 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02720777 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01651940 |
| 67 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.00637811 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00344822 |
| 69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00116046 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.99597711 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.98926419 |
| 72 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.97599590 |
| 73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97516900 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.96149373 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95566276 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.93036543 |
| 77 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92406168 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91287293 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90136354 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89596452 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88669711 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88214987 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88082835 |
| 84 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87125297 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87035460 |
| 86 | Salmonella infection_Homo sapiens_hsa05132 | 0.86937798 |
| 87 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.86706938 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.86162410 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85267370 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83470880 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83329065 |
| 92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82549336 |
| 93 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.82373769 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81570495 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81419814 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80694300 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80602179 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79931893 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79395436 |
| 100 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78528076 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78065421 |
| 102 | Allograft rejection_Homo sapiens_hsa05330 | 0.77000486 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76716947 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.76172664 |
| 105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75250825 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74634312 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.74551655 |
| 108 | Pertussis_Homo sapiens_hsa05133 | 0.73752780 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72576719 |
| 110 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72310028 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68590881 |
| 112 | Cell cycle_Homo sapiens_hsa04110 | 0.68394113 |
| 113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67817464 |
| 114 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67534932 |
| 115 | RNA degradation_Homo sapiens_hsa03018 | 0.66670434 |
| 116 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65436693 |
| 117 | Peroxisome_Homo sapiens_hsa04146 | 0.63267336 |
| 118 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63008270 |
| 119 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62951619 |
| 120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62908877 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62854126 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62177301 |
| 123 | Measles_Homo sapiens_hsa05162 | 0.61977640 |
| 124 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.61437182 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60031740 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59978237 |
| 127 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59772812 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59718865 |
| 129 | Purine metabolism_Homo sapiens_hsa00230 | 0.59642173 |
| 130 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59266163 |
| 131 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58977294 |
| 132 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58970023 |
| 133 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57962231 |
| 134 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57684131 |
| 135 | RNA transport_Homo sapiens_hsa03013 | 0.57438860 |
| 136 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57403930 |
| 137 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57118091 |
| 138 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56380654 |
| 139 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55747562 |
| 140 | Legionellosis_Homo sapiens_hsa05134 | 0.55543249 |
| 141 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54998934 |
| 142 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54275601 |
| 143 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.53771169 |
| 144 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53472034 |
| 145 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53422186 |
| 146 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53358795 |
| 147 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53192200 |
| 148 | Bladder cancer_Homo sapiens_hsa05219 | 0.52272489 |
| 149 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51210005 |
| 150 | Leishmaniasis_Homo sapiens_hsa05140 | 0.47916447 |
| 151 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47802882 |
| 152 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47489466 |
| 153 | Apoptosis_Homo sapiens_hsa04210 | 0.46891541 |
| 154 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45700038 |
| 155 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45639598 |
| 156 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45423035 |
| 157 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44413092 |
| 158 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44051814 |
| 159 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42587027 |
| 160 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40022374 |
| 161 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.38907656 |
| 162 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36586698 |
| 163 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.35670709 |
| 164 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35303730 |
| 165 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34376738 |
| 166 | Malaria_Homo sapiens_hsa05144 | 0.34230957 |
| 167 | Retinol metabolism_Homo sapiens_hsa00830 | 0.34222681 |
| 168 | Shigellosis_Homo sapiens_hsa05131 | 0.34213241 |
| 169 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.33237351 |
| 170 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32566387 |

